Ultravist 370mg I/ml Injection
By Ultravist
Rx
100ml Injection in a Vial

Composition
Iopromide(370mg I/ml)

Manufacturer - Zydus Cadila
Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after
October, 2025

liver
When it comes to the safety of using Ultravist 370mg I/ml Injection, it is important to be cautious if you have severe liver disease. Patients with severe liver issues may require a dose adjustment when using Ultravist 370mg I/ml Injection. It is advised to consult your doctor before using this injection to ensure proper guidance and safety measures are in place.

kidney
Ultravist 370mg I/ml Injection requires caution in severe kidney disease patients. Dosage may need adjustment. Consult your doctor.

alcohol
Consult your doctor when consuming alcohol with Ultravist 370mg I/ml Injection.

driving
"It is advisable not to drive if you encounter symptoms that hinder concentration and reaction time when using Ultravist 370mg I/ml Injection."

pregnancy
Ultravist 370mg I/ml Injection is believed to be safe during pregnancy based on animal studies. Limited human studies suggest it may not harm the developing baby.

breastfeeding
Caution is advised when breastfeeding while using Ultravist 370mg I/ml Injection, as it may be unsafe. Limited data indicates potential harm to the baby through breastmilk transmission.
Habit Forming | No |
Chemical Class | 4-Halobenzoic Acids Derivative |
Therapeutic Class | - |
Action Class | X ray contrast media (Diagnostic agents) |
₹1757.86
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024